MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Blood Processing, Blood Pumps, Diagnostics, Hemorrhage, Bleeding, Hemostatis, Transfusion, Intravenous (IV) Management
Haermonics BV
Organization & Developments: Haermonics
Parents
Haermonics BV
Children
*Innovative flushing therapy that reduces blood loss and the need for re-operations
*The LAEBROIDES® System works by reducing clogging of the chest tubes, thereby maintaining patency of the drainage and preventing subsequent accumulation of blood and clots in the pericardial space.
*The system monitors the post-operative blood loss and intra-cavital pressure.
2021: FDA Breakthrough Device Designation granted for Haermonics Laebroides pericardial flushing device
2025: Medical device to prevent blood-related complications after open-heart surgery.
Jumps
Finance & Acquisition: Haermonics
Key People: Haermonics